Gen9 Expands Scientific Advisory Board to Advance Synthetic Biology
9/25/2012 9:51:13 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gen9, Inc., a pioneer in the development of scalable technologies for gene synthesis, today announced the newest members of its already impressive Scientific Advisory Board (SAB). In addition to advising the company on product development and future directions, SAB members will participate in selecting the winners of the G-Prize, which celebrates and supports innovation in the constructive application of synthetic DNA libraries.
comments powered by